Literature DB >> 21381411

[Primary hepatic lymphoma: an infrequent cause of focal hepatic lesion].

Carolina Balduzzi1, Martin Yantorno, Iván Mosca, Mirta Apraiz, María J Velázquez, María del Carmen Puente, Valeria Moragrega, Regina Ligorría, Anabel Ottino, Rodrigo Belloni, Rodolfo Barbero, Alejandro Jmelniztky, Néstor Chopita.   

Abstract

Primary hepatic lymphoma (PHL) is confined to the liver with no evidence of extrahepatic lymphomatosis. Histopathologically, the PHL belongs to the group of non-Hodgkin's lymphomas and the most common subtype is the diffise large B-cell lymphoma. We present a 72-year-old woman, with no relevant antecedents and the following symptoms: early satiety, abdominal discomfort and rapid weight loss. Liver function tests are normal, erythrocyte sedimentation rate is accelerated and LDH progressively increases during the hospitalization. Imaging studies (ultrasound, CT scan, nuclear magnetic resonance) show a multilobued mass of around 12 cm of diameter in the right hepatic lobe. Tumoral and virological markers are negative. The pathology of an echo-guided biopsy informs a massive infiltration by a diffuse large B-cell lymphoma. The immunohistochemical study shows CD20+, CD45+ and negative CD3, CKAE1, AE3, Hepatocyte and HMB45. The citology of pleural liquid is negative for atypia, peripheral blood smear shows no signs of leukemia, bone marrow biopsy is negative for lymphomatous infiltration, and gallium scintigraphy and body CT scan do not reveal extrahepatic lesions. The patient starts chemotherapy with cyclophosphamide and methylprednisolone but worsens and dies two weeks after beginning treatment. We conclude that our patient had a rare disease with an unresectable lesion, poor prognostic factors and high recurrence risk. Chemotherapy is the treatment of choice in these cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21381411

Source DB:  PubMed          Journal:  Acta Gastroenterol Latinoam        ISSN: 0300-9033


  2 in total

1.  An unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review.

Authors:  Sih-Han Liao; Yin-Kai Chen; Shan-Chi Yu; Ming-Shiang Wu; Hsiu-Po Wang; Ping-Huei Tseng
Journal:  SAGE Open Med Case Rep       Date:  2017-05-26

2.  Diffusion weighted MR and apparent diffusion coefficient measurement in classification and characterization of noncystic focal liver lesions: does a clinical role exist?

Authors:  Francesco Mungai; Mario Morone; Alberta Villanacci; Maria Pia Bondioni; Lorenzo Nicola Mazzoni; Luigi Grazioli; Stefano Colagrande
Journal:  Medicine (Baltimore)       Date:  2014-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.